Daniel O'Day

Chairman & CEO, Gilead Sciences | Delivering Transformative Therapies through Innovation | Board Member, Georgetown University & PhRMA

San Francisco Bay Area

About

Working with Gilead employees around the world to create new possibilities in medicine. Delivering on our long term commitment to groundbreaking science and access so we can help make the world a better, healthier place.

Experience

  • Board Member at Georgetown University
    Jul 2023 - Present · 3 yrs

  • Chairman and Chief Executive Officer at Gilead Sciences
    Mar 2019 - Present · 7 yrs 4 mos

  • Board Member at PhRMA
    Mar 2019 - Present · 7 yrs 4 mos

  • Board Member at Galapagos
    Oct 2019 - 2024 · 4 yrs 4 mos

  • Roche (32 yrs 1 mo)
    • Chief Executive Officer, Roche Pharmaceuticals
      2016 - 2019 · 3 yrs

    • Chief Operating Officer, Pharma Division
      2012 - 2016 · 4 yrs

    • Chief Operating Officer, Diagnostics Division
      2010 - 2012 · 2 yrs